- 24 h
- letzte 200 News
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| 10.12.24 | Roche announces five-year results for Polivy combination in diffuse large B-cell lymphoma | ||
| 09.12.24 | Sanofi's rilzabrutinib shows promise in phase 3 immune thrombocytopenia study | ||
| 09.12.24 | Regeneron shares positive late-stage results for poze-cemdi in rare blood disorder PNH | ||
| 06.12.24 | Sanofi unveils plans to build €1bn insulin production base in China | ||
| 06.12.24 | Amgen announces $1bn investment to establish new US drug manufacturing facility | ||
| 05.12.24 | GSK and Rgenta to develop RNA-targeting small molecules in deal worth up to $500m per target | ||
| 05.12.24 | LEO Pharma's Anzupgo cream granted MHRA approval to treat chronic hand eczema | ||
| 05.12.24 | ICR study reveals how PARP inhibitor resistance develops in prostate cancer patients | ||
| 05.12.24 | AstraZeneca appoints Iskra Reic as executive vice president international | ||
| 04.12.24 | Ipsen enters $610m licensing deal with Biomunex to advance MAIT-cell engager | ||
| 04.12.24 | NICE recommends Immunocore's Kimmtrak as first drug for aggressive eye cancer | ||
| 04.12.24 | Best practices for conquering data management challenges in the pharma industry | ||
| 03.12.24 | Novartis gains rights to PTC's Huntington's programme in deal worth up to $2.9bn | ||
| 03.12.24 | Amgen's investigational weight-loss drug MariTide shows promise in mid-stage study | ||
| 03.12.24 | Bridging gaps and breaking barriers in pharma alliances | ||
| 02.12.24 | MHRA urges companies to prepare for Windsor Framework for medicines | ||
| 02.12.24 | Merck shares positive phase 3 results for pulmonary arterial hypertension therapy | ||
| 02.12.24 | Enabling a sustainable and mutually beneficial CDMO partnership | ||
| 29.11.24 | UK researchers uncover first new asthma and COPD attack treatment in 50 years | ||
| 29.11.24 | GSK granted EC approval for meningococcal disease vaccine Menveo | ||
| 29.11.24 | Galderma announces positive late-stage results for nemolizumab in prurigo nodularis | ||
| 29.11.24 | Health equity: what will you do? | ||
| 28.11.24 | AstraZeneca announces positive results for Truqap in phase 3 prostate cancer study | ||
| 28.11.24 | BeiGene's Tevimbra approved by EC for first-line gastric and oesophageal cancer use | ||
| 28.11.24 | Sanofi opens €558m modular concept manufacturing facility in Singapore |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
